Related references
Note: Only part of the references are listed.Selection of Plasmodium falciparum Multidrug Resistance Gene 1 Alleles in Asexual Stages and Gametocytes by Artemether-Lumefantrine in Nigerian Children with Uncomplicated Falciparum Malaria
C. T. Happi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Dynamics of Malaria Drug Resistance Patterns in the Amazon Basin Region following Changes in Peruvian National Treatment Policy for Uncomplicated Malaria
David J. Bacon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Disruption of a Plasmodium falciparum Multidrug Resistance-associated Protein (PfMRP) Alters Its Fitness and Transport of Antimalarial Drugs and Glutathione
Dipak Kumar Raj et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
In Vivo Selection of Plasmodium falciparum Parasites Carrying the Chloroquine-Susceptible pfcrt K76 Allele after Treatment with Artemether-Lumefantrine in Africa
Christin Sisowath et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial
M. F. Gomes et al.
LANCET (2009)
Field-based evidence of fast and global increase of Plasmodium falciparum drug-resistance by DNA-microarrays and PCR/RFLP in Niger
Maman Laminou Ibrahim et al.
MALARIA JOURNAL (2009)
Polymorphism of PfATPase in Niger: detection of three new point mutations
Maman Laminou Ibrahim et al.
MALARIA JOURNAL (2009)
A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria
Stephane Picot et al.
MALARIA JOURNAL (2009)
Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia
William O. Rogers et al.
MALARIA JOURNAL (2009)
Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia
Pharath Lim et al.
MALARIA JOURNAL (2009)
Changes in the Treatment Responses to Artesunate-Mefloquine on the Northwestern Border of Thailand during 13 Years of Continuous Deployment
Verena Ilona Carrara et al.
PLOS ONE (2009)
In-vivo efficacy of amodiaquine-artesunate in children with uncomplicated Plasmodium falciparum malaria in western Kenya
J. I. Thwing et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2009)
Use of high-density tiling microarrays to identify mutations globally and elucidate mechanisms of drug resistance in Plasmodium falciparum
Neekesh V. Dharia et al.
GENOME BIOLOGY (2009)
Detection of genome-wide polymorphisms in the AT-rich Plasmodium falciparum genome using a high-density microarray
Hongying Jiang et al.
BMC GENOMICS (2008)
Rectal artemisinins for malaria: a review of efficacy and safety from individual patient data in clinical studies
Melba Gomes et al.
BMC INFECTIOUS DISEASES (2008)
Diversity of the sarco/endoplasmic reticulum Ca2+-ATPase orthologue of Plasmodium falciparum (PfATP6)
Sabina Dahlstrom et al.
INFECTION GENETICS AND EVOLUTION (2008)
Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon
Michael Ramharter et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Artemisinin derivatives versus quinine in treating severe malaria in children: a systematic review
George PrayGod et al.
MALARIA JOURNAL (2008)
No PfATPase6 S769N mutation found in Plasmodium falciparum isolates from China
Guoqing Zhang et al.
MALARIA JOURNAL (2008)
Access to artemisinin combination therapy for malaria in remote areas of Cambodia
Shunmay Yeung et al.
MALARIA JOURNAL (2008)
A Trial of Combination Antimalarial Therapies in Children from Papua New Guinea
Harin A. Karunajeewa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Evidence of Artemisinin-Resistant Malaria in Western Cambodia
Harald Noedl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Detection of novel point mutations in the Plasmodium falciparum ATPase6 candidate gene for resistance to artemisinins
Michela Menegon et al.
PARASITOLOGY INTERNATIONAL (2008)
Qinghaosu (Artemisinin): The price of success
N. J. White
SCIENCE (2008)
A network to monitor antimalarial drug resistance: a plan for moving forward
Carol Hopkins Sibley et al.
TRENDS IN PARASITOLOGY (2008)
Recent highlights in antimalarial drug resistance and chemotherapy research
David A. Fidock et al.
TRENDS IN PARASITOLOGY (2008)
Artemisinins: their growing importance in medicine
Sanjeev Krishna et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Herba Artemisiae annuae tea preparation compared to sulfadoxine-pyrimethamine in the treatment of uncomplicated falciparum malaria in adults:: a randomized double-blind clinical trial
Christoph H. Blanke et al.
TROPICAL DOCTOR (2008)
Combating counterfeit drugs
[Anonymous]
LANCET (2008)
Genome-wide SNP genotyping highlights the role of natural selection in Plasmodium falciparum population divergence
Daniel E. Neafsey et al.
GENOME BIOLOGY (2008)
Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border
Chansuda Wongsrichanalai et al.
EMERGING INFECTIOUS DISEASES (2008)
A collaborative epidemiological investigation into the criminal fake artesunate trade in South East Asia
Paul N. Newton et al.
PLOS MEDICINE (2008)
Production of artemisinin by genetically-modified microbes
Qingping Zeng et al.
BIOTECHNOLOGY LETTERS (2008)
In vitro monitoring of Plasmodium falciparum drug resistance in French Guiana: a synopsis of continuous assessment from 1994 to 2005
Eric Legrand et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Artemisinin induces calcium-dependent protein secretion in the protozoan parasite Toxoplasma gondii
Kisaburo Nagamune et al.
EUKARYOTIC CELL (2007)
Trioxaquines and heme-artemisinin adducts inhibit the in vitro formation of hemozoin better than chloroquine
Christophe Loup et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
The Fe2+-mediated decomposotion, PfATP6 binding, and antimalarial activities of artemisone and other arteminisins:: The unlikehood of C-centered radicals as bioactive intermediates
Richard K. Haynes et al.
CHEMMEDCHEM (2007)
Genetic linkage and association analyses for trait mapping in Plasmodium falciparum
Xinzhuan Su et al.
NATURE REVIEWS GENETICS (2007)
Gene encoding a deubiquitinating enzyme is mutated in artesunate- and chloroquine-resistant rodent malaria parasites
Paul Hunt et al.
MOLECULAR MICROBIOLOGY (2007)
Rectal administration of artemisinin derivatives for the treatment of malaria
Harin A. Karunajeewa et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Artemisinin antimalarials moderately affect cytochrome P450 enzyme activity in healthy subjects
Sara Asimus et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2007)
In vitro assessment of artesunate, artemether and amodiaquine susceptibility and molecular analysis of putative resistance-associated mutations of Plasmodium falciparum from Sao Tome and Principe
Isabel D. Ferreira et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2007)
The safety of artemisinins during pregnancy: a pressing question
Stephanie Dellicour et al.
MALARIA JOURNAL (2007)
Mechanism of antimalarial action of the synthetic trioxoane RBX11160 (OZ277)
Anne-Catrin Uhlemann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
A genome-wide map of diversity in Plasmodium falciparum
Sarah K. Volkman et al.
NATURE GENETICS (2007)
Genome-wide variation and identification of vaccine targets in the Plasmodium falciparum genome
Jianbing Mu et al.
NATURE GENETICS (2007)
Artemether/lumefantrine in the treatment of uncomplicated falciparum malaria
Gilbert Kokwaro et al.
EXPERT OPINION ON PHARMACOTHERAPY (2007)
Genome variation and evolution of the malaria parasite Plasmodium falciparum
Daniel C. Jeffares et al.
NATURE GENETICS (2007)
Evidence for a common non-heme chelatable-iron-dependent activation mechanism for semisynthetic and synthetic endoperoxide antimalarial drugs
Paul A. Stocks et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2007)
Molecular monitoring of Plasmodium falciparum resistance to artemisinin in Tanzania
Kefas Mugittu et al.
MALARIA JOURNAL (2006)
No hearing loss associated with the use of artemether-lumefantrine to treat experimental human malaria
Matthew B. B. McCall et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2006)
In vitro inhibition of Toxoplasma gondii by four new derivatives of artemisinin
Lorraine Jones-Brando et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia
Mey Bouth Denis et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2006)
Transporters involved in resistance to antimalarial drugs
Stephanie G. Valderramos et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
An open label randomized comparison of mefloquine-artesunate as separate tablets vs. a new co-formulated combination for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand
Elizabeth A. Ashley et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2006)
Are currently deployed artemisinins neurotoxic?
Stephen Toovey
TOXICOLOGY LETTERS (2006)
Plasmodium vinckei:: Selection of a strain exhibiting stable resistance to arteether
S. K. Puri et al.
EXPERIMENTAL PARASITOLOGY (2006)
Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia
Mey Bouth Denis et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2006)
Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin
Amar Bir Singh Sidhu et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Genetic linkage of pfmdr1 with food vacuolar solute import in Plasmodium falciparum
Petra Rohrbach et al.
EMBO JOURNAL (2006)
The history of qing hao in the Chinese materia medica
E Hsu
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2006)
Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria
RN Price et al.
CLINICAL INFECTIOUS DISEASES (2006)
Reflections on the 'discovery' of the antimalarial qinghao
Elisabeth Hsu
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
A systematic map of genetic variation in Plasmodium falciparum
Claire Kidgell et al.
PLOS PATHOGENS (2006)
Re-evaluation of how artemisinins work in light of emerging evidence of in vitro resistance
Sanjeev Krishna et al.
TRENDS IN MOLECULAR MEDICINE (2006)
In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003
S Vijaykadga et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2006)
Malaria parasites can develop stable resistance to artemisinin but lack mutations in candidate genes atp6 (Encoding the sarcoplasmic and endoplasmic reticulum Ca2+ ATPase), tctp, mdr1, and cg10
A Afonso et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6
R Jambou et al.
LANCET (2005)
Artemisinin-based combinations
EA Ashley et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2005)
Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania
A Mårtensson et al.
CLINICAL INFECTIOUS DISEASES (2005)
The antimalarial drug artemisinin alkylates heme in infected mice
A Robert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Yeast model uncovers dual roles of mitochondria in the action of arternisinin
W Li et al.
PLOS GENETICS (2005)
Drug resistance hampers our capacity to roll back malaria
P Olliaro
CLINICAL INFECTIOUS DISEASES (2005)
pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum
ABS Sidhu et al.
MOLECULAR MICROBIOLOGY (2005)
A single amino acid residue can determine the sensitivity of SERCAs to artemisinins
AC Uhlemann et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2005)
Three-dimensional structure of Plasmodium falciparum Ca2+-ATPase(PfATP6) and docking of artemisinin derivatives to PfATP6
M Jung et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Are transporter genes other than the chloroquine resistance locus (pfcrt) and multidrug resistance gene (pfmdr) associated with antimalarial drug resistance?
TJC Anderson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Efficacy of combination therapy with artesunate plus amodiaquine compared to monotherapy with chloroquine, amodiaquine or sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum in Afghanistan
N Durrani et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2005)
Heme alkylation by artesunic acid and trioxaquine DU1301, two antimalarial trioxanes
SAL Laurent et al.
CHEMBIOCHEM (2005)
In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem)
C Sisowath et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Artemisinins
CJ Woodrow et al.
POSTGRADUATE MEDICAL JOURNAL (2005)
Reaction of artemisinin with haemoglobin: implications for antimalarial activity
R Kannan et al.
BIOCHEMICAL JOURNAL (2005)
Artemisinin resistance: how can we find it?
H Noedl
TRENDS IN PARASITOLOGY (2005)
Piperaquine - A resurgent antimalarial drug
TME Davis et al.
DRUGS (2005)
C10-modified artemisinin derivatives: Efficient heme-alkylating agents
SAL Laurent et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2005)
Artemisinin derivatives: toxic for laboratory animals, safe for humans?
T Gordi et al.
TOXICOLOGY LETTERS (2004)
Development of artemisinin and its structurally simplified trioxane derivatives as antimalarial drugs
P Ploypradith
ACTA TROPICA (2004)
Plasmodium yoelii:: Identification and partial characterization of an mdr1 gene in an artemisinin-resistant line
I Ferrer-Rodríguez et al.
JOURNAL OF PARASITOLOGY (2004)
Genetic mapping in the human malaria parasite Plasmodium falciparum
XZ Su et al.
MOLECULAR MICROBIOLOGY (2004)
Artemisinins: mechanisms of action and potential for resistance
S Krishna et al.
DRUG RESISTANCE UPDATES (2004)
Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number
RN Price et al.
LANCET (2004)
Antimalarial drug toxicity - A review
WRJ Taylor et al.
DRUG SAFETY (2004)
Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials
AM Dondorp et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2004)
Highly antimalaria-active artemisinin derivatives: Biological activity does not correlate with chemical reactivity
RK Haynes et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2004)
Artemisinins: activities and actions
RK Haynes et al.
MICROBES AND INFECTION (2004)
Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether
S Toovey et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2004)
Randomized controlled trial of a traditional preparation of Artemisia annua L. (Annual Wormwood) in the treatment of malaria
MS Mueller et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2004)
Treatment of uncomplicated falciparum malaria in southern Vietnam: Can chloroquine or sulfadoxine-pyrimethamine be reintroduced in combination with artesunate?
NM Huong et al.
CLINICAL INFECTIOUS DISEASES (2003)
Probing the possible molecular origin of the highly selective toxicity of antimalarial peroxide Qinghaosu (Axtemisinin)
YK Wu et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2003)
A selective sweep driven by pyrimethamine treatment in southeast Asian malaria parasites
S Nair et al.
MOLECULAR BIOLOGY AND EVOLUTION (2003)
Artemisinins target the SERCA of Plasmodium falciparum
U Eckstein-Ludwig et al.
NATURE (2003)
Resistance to antimalarials in southeast Asia and genetic polymorphisms in pfmdr1
AL Pickard et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Multiple transporters associated with malaria parasite responses to chloroquine and quinine
JB Mu et al.
MOLECULAR MICROBIOLOGY (2003)
Artemisinin autoinduction is caused by involvement of cytochrome P4502B6 but not 2C9
USH Simonsson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Study on the mechanism of action of artemether against schistosomes: The identification of cysteine adducts of both carbon-centred free radicals derived from artemether
WM Wu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
The de novo selection of drug-resistant malaria parasites
NJ White et al.
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2003)
Characterisation of the human liver in vitro metabolic pattern of artemisinin and auto-induction in the rat by use of nonlinear mixed effects modelling
USH Svensson et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2003)
Artemisinin antimalarials do not inhibit hemozoin formation
RK Haynes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
In-vivo therapeutic efficacy trial with artemisinin derivative, buparvaquone and imidocarb dipropionate against Babesia equi infection in donkeys
S Kumar et al.
JOURNAL OF VETERINARY MEDICAL SCIENCE (2003)
An over four millennium story behind qinghaosu (Artemisinin) - A fantastic antimalarial drug from a traditional Chinese herb
Y Li et al.
CURRENT MEDICINAL CHEMISTRY (2003)
Artemisinin: mechanisms of action, resistance and toxicity
SR Meshnick
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2002)
Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam
GT Phan et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2002)
Glucuronidation of dihydroartemisinin in vivo and by human liver microsomes and expressed UDP-glucuronosyltransferases
KF Ilett et al.
DRUG METABOLISM AND DISPOSITION (2002)
Iron chelators as antimalarial agents:: in vitro activity of dicatecholate against Plasmodium falciparum
B Pradines et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum
JC Wootton et al.
NATURE (2002)
Artemisinin pharmacokinetics and efficacy in uncomplicated-malaria patients treated with two different dosage regimens
T Gordi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Heme-artemisinin adducts are crucial mediators of the ability of artemisinin to inhibit heme polymerization
R Kannan et al.
CHEMISTRY & BIOLOGY (2002)
Apparent drug failure following artesunate treatment of Plasmodium falciparum malaria in Freetown, Sierra Leone:: four case reports
F Sahr et al.
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY (2001)
Possible modes of action of the artemisinin-type compounds
PL Olliaro et al.
TRENDS IN PARASITOLOGY (2001)
Mutations in the P-falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance
DA Fidock et al.
MOLECULAR CELL (2000)
Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine
A Brockman et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2000)
Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand:: a prospective study
F Nosten et al.
LANCET (2000)
Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum
MB Reed et al.
NATURE (2000)
The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin
MT Duraisingh et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2000)
Mechanisms of artemisinin resistance in the rodent malaria pathogen Plasmodium yoelii
DJ Walker et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
A possible antimalarial action mode of qinghaosu (artemisinin) series compounds. Alkylation of reduced glutathione by C-centered primary radicals produced from antimalarial compound qinghaosu and 12-(2,4-dimethoxyphenyl)-12-deoxoqinghaosu
DY Wang et al.
CHEMICAL COMMUNICATIONS (2000)
Share Paper
